Ductus Venosus Doppler in IUGR Pregnancies
IUGR-DV
Longitudinal Assessment of Ductus Venosus Doppler Parameters and Their Association With Perinatal Outcomes in Pregnancies With Intrauterine Growth Restriction
1 other identifier
observational
81
1 country
1
Brief Summary
This prospective observational cohort study aims to evaluate the relationship between ductus venosus Doppler parameters and perinatal outcomes in pregnancies complicated by intrauterine growth restriction (IUGR). Pregnant women diagnosed with IUGR will undergo longitudinal Doppler assessments of the ductus venosus during the third trimester. The Doppler indices will be correlated with perinatal outcomes, including Apgar scores, neonatal intensive care unit (NICU) admission, and perinatal mortality. The study seeks to determine whether serial ductus venosus Doppler measurements can serve as predictive markers of adverse neonatal outcomes in IUGR pregnancies.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Sep 2025
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 1, 2025
CompletedFirst Submitted
Initial submission to the registry
September 13, 2025
CompletedFirst Posted
Study publicly available on registry
September 25, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 1, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
March 1, 2026
CompletedMarch 17, 2026
March 1, 2026
5 months
September 13, 2025
March 14, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Composite adverse perinatal outcome (perinatal mortality, Apgar score <7 at 5 minutes, NICU admission)
A composite outcome including perinatal mortality, Apgar score \<7 at 5 minutes, and NICU admission. The association between ductus venosus Doppler indices and this composite outcome will be analyzed.
From delivery until neonatal discharge (up to 28 days postpartum)
Secondary Outcomes (1)
Longitudinal change (slope) of ductus venosus PI during third trimester
From study enrollment through delivery (up to 14 weeks), assessed weekly
Study Arms (1)
IUGR Pregnancies
Pregnant women diagnosed with intrauterine growth restriction will be followed longitudinally with serial ductus venosus Doppler assessments during the third trimester. Perinatal outcomes will be recorded until delivery and the early neonatal period.
Eligibility Criteria
Pregnant women aged 18-45 years with singleton pregnancies diagnosed with intrauterine growth restriction (IUGR) will be recruited from the Department of Perinatology at Izmir City Hospital. Eligible participants will be followed with serial Doppler ultrasound examinations of the ductus venosus during the third trimester and monitored until delivery and the early neonatal period.
You may qualify if:
- Female participants aged 18-45 years
- Singleton pregnancy
- Intrauterine growth restriction (IUGR) with estimated fetal weight \<10th percentile for gestational age
- Gestational age ≥24 weeks at enrollment
- Ability to comply with scheduled follow-up visits and Doppler examinations
- Signed informed consent obtained
You may not qualify if:
- Multiple gestations (twins or higher-order pregnancies)
- Major fetal congenital anomalies
- Known chromosomal abnormalities
- Maternal chronic systemic diseases likely to affect fetal growth (e.g., uncontrolled diabetes mellitus, severe renal disease, severe hypertension)
- Maternal infections known to impact fetal growth (e.g., TORCH infections)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Izmir City Hospital
Izmir, Bayrakli, 35540, Turkey (Türkiye)
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Hakan Golbasi, Assistant Professor
Izmir City Hospital
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Target Duration
- 3 Months
- Sponsor Type
- OTHER GOV
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- MD, Perinatology Specialist
Study Record Dates
First Submitted
September 13, 2025
First Posted
September 25, 2025
Study Start
September 1, 2025
Primary Completion
February 1, 2026
Study Completion
March 1, 2026
Last Updated
March 17, 2026
Record last verified: 2026-03
Data Sharing
- IPD Sharing
- Will not share
Individual participant data (IPD) will not be shared because the dataset is limited to a single-center observational study and will only be used for publication of aggregated results.